INO News

Pomerantz LLP Pursues Class Action Litigation Against Inovio Pharmaceuticals, Inc. – INO

INO SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

Pomerantz LLP Pursues Class Action Lawsuit Against Inovio Pharmaceuticals, Inc.  – INO

INO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Pursues Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INO

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INO

Pomerantz LLP Pursues Class Action Against Inovio Pharmaceuticals, Inc.  – INO

ROSEN, A LONGSTANDING LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INO

Pomerantz LLP Pursues Class Action Against Inovio Pharmaceuticals, Inc. – INO